Skip to main content

Peer Review reports

From: PARP inhibitors chemopotentiate and synergize with cisplatin to inhibit bladder cancer cell survival and tumor growth

Original Submission
4 Aug 2021 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
24 Oct 2021 Reviewed Reviewer Report
28 Oct 2021 Reviewed Reviewer Report
3 Dec 2021 Author responded Author comments - Nagalakshmi Nadiminty
Resubmission - Version 3
3 Dec 2021 Submitted Manuscript version 3
21 Dec 2021 Author responded Author comments - Nagalakshmi Nadiminty
Resubmission - Version 4
21 Dec 2021 Submitted Manuscript version 4
7 Jan 2022 Author responded Author comments - Nagalakshmi Nadiminty
Resubmission - Version 5
7 Jan 2022 Submitted Manuscript version 5
3 Feb 2022 Reviewed Reviewer Report
9 Feb 2022 Reviewed Reviewer Report
11 Feb 2022 Author responded Author comments - Nagalakshmi Nadiminty
Resubmission - Version 6
11 Feb 2022 Submitted Manuscript version 6
15 Feb 2022 Author responded Author comments - Nagalakshmi Nadiminty
Resubmission - Version 7
15 Feb 2022 Submitted Manuscript version 7
Publishing
7 Mar 2022 Editorially accepted
23 Mar 2022 Article published 10.1186/s12885-022-09376-9

You can find further information about peer review here.

Back to article page